The Chappel Group Research is a clinical research site located in Kissimmee, Florida, United States 34741.
Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.
The Chappel Group Research has participated in 10 clinical trials.
Therapeutic areas: Irritable Bowel Syndrome Characterized by Constipation, Obesity, Overweight.
Sponsors: Ironwood Pharmaceuticals, Inc., Novo Nordisk A/S, Encube Ethicals Pvt. Ltd..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Kissimmee
Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Chappel Group Research has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Chappel Group Research has 10 clinical trials on record. Their work covers Irritable Bowel Syndrome Characterized by Constipation, Obesity, Overweight.
The Chappel Group Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.